MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with P

Potassium citrate

Potassium citrate 1.08g modified-release tablets

No stability information

Stability notes for Potassium citrate 1.08g modified-release tablets

There are no stability notes for this medicine.

Suppliers

Renodyra 1080mg modified-release tablets (Penlan Pharmaceuticals Ltd)
Urocit-K 10mEq tablets (Imported (United States))

Potassium citrate 280mg capsules

No stability information

Stability notes for Potassium citrate 280mg capsules

There are no stability notes for this medicine.

Supplier

Potassium citrate 280mg capsules (Special Order)

Potassium citrate 540mg modified-release tablets

No stability information

Stability notes for Potassium citrate 540mg modified-release tablets

There are no stability notes for this medicine.

Supplier

Urocit-K 5mEq tablets (Imported (United States))

Potassium citrate 600mg capsules

No stability information

Stability notes for Potassium citrate 600mg capsules

There are no stability notes for this medicine.

Supplier

Potassium citrate 600mg capsules (Special Order)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.